ArticleFrontiers in pharmacology2021

Targeting Nrf2-Mediated Oxidative Stress Response Signaling Pathways as New Therapeutic Strategy for Pituitary Adenomas.

Xianquan Zhan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.